SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (1923)1/25/2002 7:40:09 PM
From: George Hassen  Respond to of 2515
 
Dr. Waksal got his doctorate at Ohio State and pursued an academic career at Stanford, the National Cancer Institute, Tufts and the Mount Sinai School of Medicine. Many former colleagues said Dr. Waksal was very bright but seemed to cut corners; some have bitter memories.

"I threw him out," said Dr. Leonard A. Herzenberg, a professor of genetics at Stanford; Dr. Waksal worked in his laboratory for a few months in the mid-1970's. Dr. Herzenberg said that for an experiment, Dr. Waksal had supplied him and another researcher with material that turned out not to be what Dr. Waksal had claimed it was. "I told him, `You've ruined weeks or months of another postdoc's efforts,' " Dr. Herzenberg recalled.

nytimes.com



To: keokalani'nui who wrote (1923)1/25/2002 7:40:37 PM
From: tom pope  Read Replies (1) | Respond to of 2515
 
Which made me suspect that Sterling is a professional shorter along the lines of Avalon. That may be the case, but I've found no smoking gun in a simple search of their website.
"Known to be ineffective" would definitely be new ground.